ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

NCI Announces Designation Of Comprehensive Center

July 20, 1990

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975

Editorial: Ambiance Through Exclusion

May 20, 1994

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001